These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37254011)

  • 41. Continuous glucose monitoring for primary care patients with diabetes: Barriers, facilitators, & resources to support access.
    Warman M; Fillippi M; Manning B; Oser T; Nease D; Hall T; Oser S; Carroll J
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36857171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How use of continuous glucose monitoring can address therapeutic inertia in primary care.
    Martens TW; Parkin CG
    Postgrad Med; 2022 Aug; 134(6):576-588. PubMed ID: 35584802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
    Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
    Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benefits of short-term professional continuous glucose monitoring in clinical practice.
    Leinung M; Nardacci E; Patel N; Bettadahalli S; Paika K; Thompson S
    Diabetes Technol Ther; 2013 Sep; 15(9):744-7. PubMed ID: 23786229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review.
    Kieu A; King J; Govender RD; Östlundh L
    J Diabetes Sci Technol; 2023 May; 17(3):762-774. PubMed ID: 35100891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study).
    Bajaj HS; Venn K; Ye C; Patrick A; Kalra S; Khandwala H; Aslam N; Twum-Barima D; Aronson R
    Diabetes Care; 2017 Feb; 40(2):194-200. PubMed ID: 27913575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
    Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
    JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delays in Continuous Glucose Monitoring Device Initiation: A Single Center Experience and a Call to Change.
    Modzelewski KL; Murati J; Charoenngam N; Rehm C; Steenkamp DW
    Diabetes Technol Ther; 2022 Jun; 24(6):390-395. PubMed ID: 35099277
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.
    Rasbach LE; Atkins AE; Milaszewski KM; Keady J; Schmidt LM; Volkening LK; Laffel LM
    J Diabetes Sci Technol; 2014 May; 8(3):494-7. PubMed ID: 24876612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine.
    Cobry EC; Reznick-Lipina T; Pyle L; Slover R; Thomas JF; Alonso GT; Wadwa RP
    Diabetes Technol Ther; 2022 Jan; 24(1):67-74. PubMed ID: 34524007
    [No Abstract]   [Full Text] [Related]  

  • 53. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years, a Population-Based Study.
    Johnson SR; Holmes-Walker DJ; Chee M; Earnest A; Jones TW; ; Craig M; Anderson K; Ambler G; Barrett H; Batch J; Bergman P; Cameron F; Colman P; Conwell L; Cooper C; Couper J; Davis E; de Bock M; Donaghue K; Fairchild J; Fegan G; Fourlanos S; Glastras S; Gray L; Hamblin S; Hofman P; Holmes-Walker DJ; Howard N; Jack M; James S; Jefferies C; Johnson S; Kao J; King BR; Lafferty A; Martin M; McCrossin R; Pascoe M; Paul R; Pawlak D; Peña A; Price S; Price D; Rodda C; Simmons D; Sinnott R; Sive A; Smart C; Stone M; Stranks S; Tham E; Verge C; Ward G; Wheeler B; Williams J; Woodhead H; Woolfield N; Zimmermann A
    Diabetes Care; 2022 Feb; 45(2):391-397. PubMed ID: 34872983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health Care Disparities in Use of Continuous Glucose Monitoring.
    Isaacs D; Bellini NJ; Biba U; Cai A; Close KL
    Diabetes Technol Ther; 2021 Sep; 23(S3):S81-S87. PubMed ID: 34546086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.
    de Portu S; Vorrink L; Re R; Shin J; Castaneda J; Habteab A; Cohen O
    BMJ Open; 2022 Feb; 12(2):e050635. PubMed ID: 35110310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.
    Bailey TS; Zisser HC; Garg SK
    Diabetes Technol Ther; 2007 Jun; 9(3):203-10. PubMed ID: 17561790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 59. Improving glucose control in patients with type 2 diabetes using retrospective continuous glucose monitoring.
    Diamond K
    J Am Assoc Nurse Pract; 2023 Jul; 35(7):425-433. PubMed ID: 36735841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin.
    Bao S; Bailey R; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 May; 24(5):299-306. PubMed ID: 34939824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.